Radcal Corporation Revenue and Competitors

Monrovia, CA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Radcal Corporation's estimated annual revenue is currently $6.8M per year.(i)
  • Radcal Corporation's estimated revenue per employee is $322,714

Employee Data

  • Radcal Corporation has 21 Employees.(i)
  • Radcal Corporation grew their employee count by -5% last year.

Radcal Corporation's People

NameTitleEmail/Phone
1
Regional Sales ManagerReveal Email/Phone
2
Co Director Global SalesReveal Email/Phone
3
Marketing CoordinatorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M7920%N/AN/A
#2
$8.5M3111%N/AN/A
#3
$4.5M13-13%N/AN/A
#4
$8M25-4%N/AN/A
#5
$5.3M16-6%N/AN/A
#6
$54.2M163-8%N/AN/A
#7
$12M55-17%N/AN/A
#8
$10M30-9%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M43-7%N/AN/A
Add Company

What Is Radcal Corporation?

Radcal is the recognized leader in radiation and invasive measurements for medical X-ray QA, X-ray test and X-ray compliance. Other applications include, but are not limited to industrial X-ray and nuclear power ionizing radiation measurements. Radcal's reputation had it's beginnings in 1975 with the introduction of the MDH 1015. The 1015 was designed for the FDA as an easy-to-use, reliable and accurate radiation measurement instrument. In 1996 Radcal acquired the Machlett DynalyzerTM product line from Fischer RMS. In doing so Radcal has become the sole manufacturer of the Dynalyzer/HV1 product line and sole source for factory approved calibrations.

keywords:N/A

N/A

Total Funding

21

Number of Employees

$6.8M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Radcal Corporation News

2022-04-17 - Radiation dose-rate is a neglected critical parameter in dose ...

... GC220s were assessed and verified using a Farmer type 0.18 cm3 free air ionization chamber (10X6-0.18, RadCal Corporation, Monrovia, CA.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.1M2210%N/A
#2
$3.2M2216%N/A
#3
$4.3M2222%N/A
#4
$4.5M23-4%N/A
#5
$4.5M240%N/A